Prevalence of Chronic Venous Disease in General Population
NCT ID: NCT03900234
Last Updated: 2019-04-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
783 participants
OBSERVATIONAL
2015-07-01
2015-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Etiology and Prevalence of Peripheral Arterial Disease
NCT00005142
Epidemiology of Cardiovascular Diseases and Their Risk Factors in Regions of Russian Federation
NCT04306822
Cardiovascular Epidemiology in Russian Federation
NCT02449460
Epidemiology of Venous Disease
NCT00005392
VEIN Health - CVD Prevalence and Characteristics
NCT04901845
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Those who agree, will be examined both clinically and by duplex ultrasound. Medical history of participants will be taken, demographic data will be collected. Possible factors that may influence CVD development will be registered.
Signs and symptoms of CVD will be registered. Duplex ultrasound will be used in every resident to reveal pathological venous reflux in deep and superficial veins.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Residents of the single rural settlement
No interventions will be administered
No intervention will be administered
No intervention will be studied. Clinical and ultrasound examinations will be used to find the prevalence of CVD.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention will be administered
No intervention will be studied. Clinical and ultrasound examinations will be used to find the prevalence of CVD.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* both female and male
* age 10 years and more
* agree to participate
* signed infromed consent
Exclusion Criteria
* not signed informed consent
10 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pirogov Russian National Research Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Igor Zolotukhin
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Igor Zolotukhin, Prof
Role: PRINCIPAL_INVESTIGATOR
Russian National Research Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pirogov Russian National Research Medical University
Moscow, , Russia
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Zolotukhin IA, Seliverstov EI, Shevtsov YN, Avakiants IP, Tatarintsev AM, Kirienko AI. Risk factors for venous symptoms in Russian patients with chronic venous disease. Curr Med Res Opin. 2019 Sep;35(9):1583-1587. doi: 10.1080/03007995.2019.1605050. Epub 2019 May 13.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.